Teva Pharmaceutical Industries Limited Announces Launch of Generic Prometrium® Capsules in the United States

Published: Mar 02, 2012

JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today the commercial launch of Progesterone Capsules, 100 & 200 mg, the AB-rated generic equivalent of Abbott Laboratories’ Prometrium® Capsules.

Back to news